IMADGIST: A RANDOMIZED STUDY OF 3 VS. 6 YEARS
OF ADJUVANT IMATINIB IN PATIENTS WITH LOCALIZED
GIST AT HIGH RISK OF RELAPSE
Axel Le Cesne, Camille Schiffler, Olivier Bouché, Mehdi Brahmi, Florence Duffaud, Maud Toulmonde, Bruno
Landi, Wahid Lahlou, Diane Pannier, Emmanuelle Bompas, Francois Bertucci, Loic Chaigneau, Olivier Collard,
Marc Pracht, Isabelle Ray-Coquard, Antoine Adenis, Benjamin Verret, Nicolas Penel, Severine Metzger, Sylvie
Chabaud, David Perol and Jean-Yves Blay